Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Pimavanserin tartrate
Acadia Pharmaceuticals B.V.
Alzheimer's Disease Psychosis
1 trial -
Pimavanserina 34 mg placebo cΓ‘psulas, Pimavanserin tartrate
The George Institute
Major depressive disorder
1 trial -
Pirfenidone Solution for Inhalation, Pirfenidone Solution for Inhalation, Placebo for AP01
Lacuna Pharma Pty Ltd
Progressive Pulmonary Fibrosis
1 trial -
Pirtobrutinib, Placebo tablets
Eli Lilly Co.
Immune Thrombocytopenia
1 trial -
Placebo
Takeda
Essential Hypertension
1 trial -
Placebo
Alnylam Netherlands B.V.
Hypertension
1 trial -
Placebo
Teva Pharma GmbH
Primary Progressive Multiple Sclerosis
1 trial -
Placebo
United Therapeutics Europe Ltd
Influenza
1 trial -
Placebo
IONIS PHARMACEUTICALS INC
NAFLD
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Anhedonia
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
Placebo
RIGEL PHARMACEUTICALS INC
Acute Respiratory Distress Syndrome
1 trial -
Placebo
RIGEL PHARMACEUTICALS INC
Asthma
1 trial -
Placebo
IRONWOOD PHARMACEUTICALS INC
Functional Constipation in Children Ages 6-17 Years
1 trial -
Placebo
Alnylam Netherlands B.V.
Cerebral Amyloid Angiopathy
1 trial -
Placebo
Alnylam Netherlands B.V.
IgA Nephropathy (IgAN)
1 trial -
Placebo
Takeda
Ulcerative Colitis
1 trial -
Placebo
Takeda
Primary Immune Thrombocytopenia
1 trial -
Placebo
Takeda
Narcolepsy Type 2
1 trial -
Placebo
Takeda
Endometriosis
2 trials -
Placebo
Takeda
Celiac Disease
1 trial -
Placebo
Takeda
Graft Rejection
1 trial -
Placebo
Takeda
Gout
1 trial -
Placebo
Regeneron UK Limited
Generalized Lipodystrophy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources